Medication info
Dairyl Tablet (Glimepiride)

Dairyl Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
Green rectangular tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201404267 · Approved 2014.09.18 · Insurance code 647203730

Summary

Main use
Improvement of glycemic control in type 2 diabetes
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect at doses above 4 mg, but some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily fails, first consider switching to insulin therapy; otherwise, consider concomitant use with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral antihyperglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is administered with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes

  • Blood glucose control issues in patients with type 2 diabetes
View approved original text

This medication helps in the control of blood glucose in patients with type 2 diabetes as an adjunct to diet and exercise. It can be used alone or in combination with oral hypoglycemic agents or insulin when blood sugar control is insufficient. Particularly, when blood sugar control is difficult with sulfonylureas or monotherapy with metformin, this drug can be used in combination with metformin to enhance effectiveness. This medication effectively assists patients in improving blood glucose management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect at doses above 4 mg, but some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg once daily fails, first consider switching to insulin therapy; otherwise, consider concomitant use with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral antihyperglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered medicine. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is administered with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Those who have had allergic reactions to this medication or to sulfonylureas, or sulfonamides should not take it. There is no experience with use in patients with severely impaired liver or kidney function, and in such cases, switching to insulin therapy is recommended. Pregnant or breastfeeding women, or those who may become pregnant, should not take this medication. Patients with severe infections or those undergoing surgery, or who have severe trauma should also be switched to insulin therapy. When there are gastrointestinal disturbances like diarrhea or vomiting, food absorption may not be adequate which increases the risk of hypoglycemia, so caution is needed. This medication contains lactose and should not be taken by those with lactose intolerance or congenital disorders such as lactase deficiency or glucose-galactose malabsorption. During the initial week of treatment, the risk of hypoglycemia is heightened, so blood glucose should be monitored frequently and symptoms should be carefully observed. Poor nutritional status, irregular eating patterns, skipping meals, imbalances between exercise and carbohydrate intake, and frequent alcohol consumption can increase the risk of hypoglycemia. Caution is also needed in individuals with impaired kidney or liver function, the elderly, and those taking other medications as the risk of hypoglycemia may be increased. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, drowsiness, confusion, dizziness, loss of consciousness, and if these symptoms occur, sugar should be ingested immediately. Visual disturbances, dyspepsia, liver dysfunction, hematological abnormalities, and allergic reactions may rarely occur, and if these symptoms arise, the patient should consult a doctor. While taking this medication, regular meals, exercise, and weight management should be implemented, and the condition of blood glucose control should be consistently monitored. In case of hypoglycemia, immediately consuming sugar or a sugary drink is the most effective solution. If undergoing treatment from another physician or pharmacist, it is essential to inform them of the intake of this medication and the state of diabetes. During stress situations like surgeries, infections, or trauma, blood glucose control may become difficult, thus temporary switching to insulin therapy may be necessary. This medication is eliminated through the kidneys, and older adults or those with decreased kidney function should be careful with dosage adjustments. In case of overdose, hypoglycemia may worsen, and prompt medical attention should be sought, even after hypoglycemia symptoms have ceased, for close observation for 1 to 2 days is necessary. When storing this medication, keep it out of the reach of children, and store it in the original container, tightly sealed. Finally, this medication may interact with other drugs, so if you are taking other medications, be sure to inform the healthcare provider.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, language abnormalities, aphasia, visual impairment, tremor, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina pectoris, venous arrhythmias, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, indigestion, facial swelling, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. Additionally, it should be stored at room temperature that is not too cold or too hot, between 1°C to 30°C.

Appearance and packaging

Appearance

Green rectangular tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.